Code | 4624A | ||||||||||
MA number | EU/1/13/817/005 | ||||||||||
Product Form: | tbl 98x40 mg/12,5 mg (blis.Al/Al) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Actavis Group PTC ehf., Iceland | ||||||||||
Therapeutic Class: | 58 - HYPOTENSIVA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 13.03.2013 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 01.07.2021 |